These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [The use of Allomaron in treating hyperuricemia]. Balkarov IM Ter Arkh; 1994; 66(1):40-2. PubMed ID: 8146793 [No Abstract] [Full Text] [Related]
23. The treatment of hyperuricemia in gout. Rastegar A; Thier SO Ration Drug Ther; 1974 Mar; 8(3):1-4. PubMed ID: 4820829 [No Abstract] [Full Text] [Related]
24. Diagnostic and therapeutic aids in gout and hyperuricemia. Bollet AJ Med Times; 1981 Aug; 109(8):23-31. PubMed ID: 7278540 [No Abstract] [Full Text] [Related]
25. Management of gout and hyperuricemia. Wisner DE; Simkin PA Prim Care; 1984 Jun; 11(2):283-94. PubMed ID: 6206519 [TBL] [Abstract][Full Text] [Related]
26. [Clinical and biological effects of a new uric acid lowering substance (benziodaronum) in gout. Results of a 2-year-long study]. Barcelo P; Santamaria A Verh Dtsch Ges Rheumatol; 1969; 1():361-70. PubMed ID: 5403652 [No Abstract] [Full Text] [Related]
27. [Basic therapy of gout by benziodarone]. Ryckewaert A; Kuntz D; Henrard JC; Puel M; de Seze S Presse Med (1893); 1969 Jul; 77(33):1157-60. PubMed ID: 4978390 [No Abstract] [Full Text] [Related]
28. [Changes in the serum concentration of uric acid under the effect of benzbromaronum]. Mertz DP Munch Med Wochenschr; 1969 Feb; 111(9):491-5. PubMed ID: 5818966 [No Abstract] [Full Text] [Related]
29. [Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver]. Mertz DP Fortschr Med; 1983 May; 101(18):851-3. PubMed ID: 6862346 [No Abstract] [Full Text] [Related]
30. [Drug therapy of hyperuricemia]. Gröbner W Verh Dtsch Ges Inn Med; 1986; 92():492-7. PubMed ID: 3811551 [No Abstract] [Full Text] [Related]
31. [Reducing the risks in the treatment of gout and hyperuricaemia (author's transl)]. Mertz DP Dtsch Med Wochenschr; 1976 Aug; 101(35):1288-92. PubMed ID: 782809 [No Abstract] [Full Text] [Related]
32. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents]. Delbarre F; Saporta L; de Géry A; Jabre E Rev Rhum Mal Osteoartic; 1970; 37(6):443-50. PubMed ID: 5453852 [No Abstract] [Full Text] [Related]
33. [Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)]. Matzkies F; Berg G Dtsch Med Wochenschr; 1976 Oct; 101(43):1568-70. PubMed ID: 991731 [TBL] [Abstract][Full Text] [Related]
34. Benzbromarone therapy in management of refractory gout. Kumar S; Ng J; Gow P N Z Med J; 2005 Jun; 118(1217):U1528. PubMed ID: 15980902 [TBL] [Abstract][Full Text] [Related]
36. [Summary of the Dutch College of General Practitioners' "Gout" Standard]. Romeijnders AC; Gorter KJ Ned Tijdschr Geneeskd; 2002 Feb; 146(7):309-13. PubMed ID: 11876034 [TBL] [Abstract][Full Text] [Related]
37. [Badly managed gout for decades. Only then do the hands look this way]. Füessl HS MMW Fortschr Med; 2006 May; 148(18):23. PubMed ID: 16736681 [No Abstract] [Full Text] [Related]
38. [How to select and use urate lowering agents for hyperuricemia]. Yamanaka H Nihon Rinsho; 1996 Dec; 54(12):3261-5. PubMed ID: 8976102 [TBL] [Abstract][Full Text] [Related]